hn.today

$300k for a personalized cancer vaccine

rnafoundry.com20 points6 comments
Screenshot of $300k for a personalized cancer vaccine

The RNA Foundry, a Hyderabad facility run by PopVax with Stochastic Sciences, offers contract research, development, and GMP-compliant manufacturing for personalized mRNA cancer vaccines. It can work from a sequence supplied by a client or help design candidates using tumour sequencing data, AI models, and open-source tools predicting immune presentation. After agreeing on a sequence, the team makes the mRNA, packages it in lipid nanoparticles, fills vials, and supplies manufacturing records, test results, and a certificate of analysis. The company says projects typically cost about $300,000 and take 8-10 weeks, subject to production availability, and that it has capacity for more than 100 vaccines over the next year.

The facility uses the mRNA and lipid-nanoparticle platform developed for PopVax’s COVID-19 vaccine candidate, which has entered clinical trials in Australia. Its proprietary lipid formulation is reported to remain stable for more than nine months under refrigeration; preclinical tests of the COVID-19 candidate produced strong CD8+ T-cell responses in mice. Quality checks include sequencing for identity, particle and RNA measurements, endotoxin testing, and sterility testing. The service responds to demand from patients and physicians seeking personalized vaccines before approvals are available across cancer types. The company points to encouraging studies combining personalized mRNA vaccines with checkpoint inhibitors in melanoma and pancreatic cancer, while positioning its manufacturing service as a route for research or regulatory-access efforts, not as an established cancer treatment.

Read on rnafoundry.com6 comments on Hacker News

Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.

More in Science

The daily digest

Today's best Hacker News stories, summarized and screenshotted, one email a day.